Loibl_LEA_ESMO2013 Final_20130923 [Schreibgeschꁧtzt]

First Page		Document Content
Date: 2013-10-02 11:16:26 Bevacizumab Fulvestrant Vascular endothelial growth factor Breast cancer Adjuvant therapy Metastatic breast cancer Eastern Cooperative Oncology Group Medicine Oncology Ribbon symbolism		Loibl_LEA_ESMO2013 Final_20130923 [Schreibgeschꁧtzt] Add to Reading List Source URL: www.germanbreastgroup.de Download Document from Source Website File Size: 229,88 KB Share Document on Facebook

	National Cancer Institute (NCI)/Division of Cancer Treatment and Diagnosis (DCTD) Conflict of Interest Policy for NCI/DCTD-supported Cooperative Group or National Clinical Trials Network Randomized Phase 2 and Phase 3 Cl DocID: 1rm5G - View Document
	The Right Place Dr. Wayne Newhauser, Dr. Charles M. Smith Chair in Medical Physics, and a team of graduate students are researching the application of 3-D scanning and printing technologies to improve cancer treatments DocID: 1rcpX - View Document
	05-AUG:10 SWOG CURRENT AND PROJECTED ACCRUAL BY COMMITTEE THERAPEUTIC STUDIES ONLY (TXCA=Y) 60% of Calendar Year is Past 18:10 Friday, August 5, 2016 DocID: 1oYjg - View Document
	05-AUG:11 OPEN SWOG INTERGROUP STUDY ACCRUAL ACCRUAL STEP ONLY ADMIN STUDY DocID: 1oPBp - View Document
	Enhancing Cancer Treatment through Improved Understanding of the Critical Components, Economics and Barriers of Cancer Clinical Trials: A policy focused guidance document commissioned by C-Change and DocID: 1oB9E - View Document